Wednesday 28 October 2015

Dos and Don’ts in presenting a Property Insurance Claim


You have met with property damage to your home or business. What to do now? How to present an insurance claim? If you already have an insurance policy, then that insurance policy is a contract between you and the insurance company. It defines what are the things to be done and what should not be done after you have had a claim. If you fail to comply with the policy’s terms, it may end up in your claim not being paid. Most people go for a home insurance policy during the closing process, without actually looking at its terms and conditions. You realize many aspects of the policy only when you are forced to make a claim. Here are a few tips for making a successful property insurance claim. 

Dos
  1. Read your policy thoroughly before submitting a claim.
  2. Secure your property to prevent additional damage
  3. Notify your insurance company/agent
  4. Find a temporary workplace/housing
  5. Get professional help to overcome the red tape
  6. Create a detailed inventory of damaged property


Don'ts
  1. Do not throw anything away
  2. Do not begin repairs until you get the insurance company’s approval
  3. Never assume you have to use the insurance company’s vendors
  4. Never allow your settlement to be paid to other parties
  5. Never respond after replacing/repairing the property
Date: Friday, 30 October 2015 | Time: 11:30 AM PDT, 02:30 PM EDT | Duration: 90 Minutes. If you cannot make it on the scheduled day, you can always buy our recorded session of the same anytime.


Wednesday 21 October 2015

Methods for Financial Statement Analysis


The huge number that appears on the financial statement of a company could be intimidating to the investors. But analyzing the financial statements will open a goldmine of information in front of you. Companies use financial statements to disclose information regarding financial performance. These statements could be used for analyzing whether to make investments in a company or not.
What are the key methods for analyzing financial statements? There are two main methods of analyzing a financial statement the first method is the use of horizontal and vertical methods and the second method is the use of ratios.
Horizontal analysis involves the comparison of financial information over a series of reporting periods, whereas vertical analysis method means the proportional analysis of a financial statement. This means every line term on a financial statement is stated as a percentage of gross sales, each line item on a balance sheet is considered as a percentage of total assets.
The second method for financial statement analysis is the use of many types of ratios. Ratios are used to calculate the relative size of one number in a relation to another. Once the ratio is calculated you can compare it with the same ratio calculated for a prior period or that is based on a certain industry average, to judge if analyzing financial statements is the use of many kinds of ratios. You use ratios to the company is performing in accordance with expectations.

To understand more on the different types of financial statements and what their intended purpose is, how to identify key operating trends and prepare financial ratios on a company's financial statements, the importance of reading the footnotes that accompany financial statements and provide an understanding of how these footnotes often hide important messages attend this webinar How to Analyze Financial Statements and Uncover the Key Trends and Hidden Messages


Friday 16 October 2015

Identification and Evaluation of Environmental Aspects


Environmental aspect of the product could be anything for example it could be the product packaging or the recyclability of the product at the end of its life cycle. According to ISO 14001, an organization must identify environmental aspects and determine those aspects that can have considerable impact to the environment. Keep a register on general environmental aspects, which is regularly updated.
Environmental aspects could be classified as direct and indirect. In order to identify the environmental aspects, a person must study how the activities and services of an organization are affecting the environment.  While identifying environmental aspects the elements which are usually considered are missions, releases to land and water, raw materials used, natural resources and impacts on the biodiversity.
Other vital techniques that could be used to evaluate environmental aspects are value chain method, materials identification method, value chain method, process flow method and value chain method.

To learn more on Recent updates on ISO 14001 attend this webinar Recent updates on ISO 14001

Thursday 8 October 2015

How to Optimize Excel Charts


Optimizing Excel Charts
Microsoft Excel Charts have evolved over the years. The functionality of the charts in Excel 2007 is almost similar to Excel 2010, while chart functionality in Excel 2013 and 2016 are almost same.
There are a number of techniques that could be used to optimize, automate, and tweak Excel charts. Creating and working with Excel charts-which can convey much more than just a sheet filled with numbers-is easy. Because charts display data in a variety of ways, using the most appropriate chart type and format enables you to display your data in the best meaningful way.

David H. Ringstrom teaches how to streamline creating and managing charts, and explores nuances that often slow Excel users down through the best selling webinar Optimizing Excel Charts

Significance of Food Recall

Plenty of control measures are being taken by food manufacturers to ensure product safety. Sometimes there are some adverse situations wherein a product manufactured and sold in the market is defective and some people fall sick or get injured, or is not in compliance with the legislation. In such a situation when a problem product has left the control of the manufacturer, it must be removed from the market or recalled.
The concern for food safety to your customers and employees must be a constant focus for all operators in the system. Ultimately, how well your company manages the crisis situations will make significant difference in how your company brand is perceived in the public's eyes and how well it succeeds in today's highly competitive marketplace. Most importantly failure to ensure food safety can jeopardize the health of your customers and could be detrimental to your business and reputation.
To understand why your company should have a crisis management plan, why having an effective product recall is critical in your company, FDA Food Safety Modernization Act, how to develop an effective crisis management program for food recall attend this webinar by Angeline Benjamin “Planning and Conducting an Effective Food Recall” Angeline Benjamin is the president of B&B Food Safety Solutions, a food safety consulting firm. She has been in the quality assurance and food safety businesses for over 30 years. Angeline began her quality assurance career at Hunt-Wesson Foods. http://www.onlinecompliancepanel.com/webinar/EffectiveFoodRecall-501024/OCT-2015-SM


Wednesday 7 October 2015

Common HMDA Reporting Requirements and Mitigation Steps

The Home Mortgage Disclosure Act (HMDA) demands covered institutions to make loan information readily available to the public. Public, industry leaders and the regulators rely on this data to analyze the performance of mortgage lenders in achieving goals that are achieved under the Equal credit Opportunity Act and the Fair Housing Act and the Community Reinvestment act. Incorrect HMDA data hurdles efforts to track discriminatory patterns that might exist in home mortgage lending and other compliance violations.
The major four errors in HMDA reporting are as follows. Errors in recording any one of these three variables will give incorrect calculations.
  • Failure to Capture All HMDA-Reportable Transactions
  • Inaccurate Loan Amount
  • Incorrect Geocoding
  • Wrong Rate Spread Calculation

Some of these mistakes are considered more significant than others. Some are more common than others. If the number of mistakes is high, it can result in rework and even fines. This can lead to loss of trust in your institution by regulators, which is never a good thing.

To learn the significance of HMDA reports, common mistakes in HMDA reports and how to reduce errors attend this webinar http://www.onlinecompliancepanel.com/webinar/HMDA-ReportingMistakes-501070/OCT-2015-SM

Monday 5 October 2015

Differences between Device and Drug Regulation

Differences between Device and Drug Regulation

Here are a few definitions: Clinical investigation is nothing but an investigation involving a test article and one or more than one human subjects.
A Drug is known as a substance recognized by an official pharmacopoeia or formulary. Drug is a substance used in diagnosis, treatments or prevention of a disease.
An investigational Drug means a new drug that is used in a clinical investigation. The term also includes a biological product that is used in vitro for diagnostic purposes.
Research Involving Drugs Exempt from IND Requirements: Research Involving Drugs Exempt from IND Requirements means a clinical research of a marketed drug (i.e, an FDA-approved drug) is exempt from the IND requirements if every criteria for exemption are truly met: The drug product is marketed in the United States lawfully; the investigation is not planned to be reported to the FDA as a well-controlled study supporting a new indication and there is no intent to use it to support any other major change in the labeling of the drug. As per the Investigational Device Exemption regulations there are three types of device investigations: Exempt Device Studies, Non-significant Risk (NSR) Device Studies and Significant Risk (SR) Device Studies.
Clinical Investigation: The term Clinical Investigation refers to any research involving one or more than one subjects to determine the safety and effectiveness of a device.

http://www.onlinecompliancepanel.com/webinar/DeviceAndDrugResearch-501007/OCT-2015-SMThis webinar will discuss the differences between device and drug clinical research and the current regulations governing the use of drugs and devices in a clinical study.